Overview

Functional Respiratory Imaging Study (FRI)

Status:
Completed

Trial end date:
2019-01-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effect of inhaled extrafine CHF5993 pMDI on airway volumes, and resistance, by Functional Respiratory Imaging (FRI), in COPD patients

Phase:

Phase 3

Details

Lead Sponsor:

Chiesi Farmaceutici S.p.A.

Treatments:

Beclomethasone
Formoterol Fumarate
Glycopyrrolate